Responsiveness of articular cartilage from normal and inflamed mouse knee joints to various growth factors

Ann Rheum Dis. 1994 Jul;53(7):455-60. doi: 10.1136/ard.53.7.455.

Abstract

Objective: Disturbed anabolic signalling might contribute to the decreased chondrocyte proteoglycan (PG) synthesis during joint inflammation. Articular cartilage obtained from mouse knee joints with experimentally-induced arthritis exhibits a state of nonresponsiveness towards stimulation of chondrocyte PG synthesis by insulin-like growth factor-1 (IGF-1). Investigations were carried out on the role of other growth factors apart from IGF-1 on regulation of chondrocyte PG synthesis under pathological conditions, that is, during repair after IL-1 exposure as well as during early and later arthritis.

Methods: Mouse patellae were obtained from normal knee joints and joints injected with IL-1 or zymosan. The patellae were cultured with basic fibroblast growth factor [bFGF], platelet-derived growth factor [PDGF], epidermal growth factor [EGF] or transforming growth factor beta [TGF beta] for 24 hours in the presence or absence of IGF-1. Chondrocyte PG synthesis was measured by 35S-sulphate incorporation.

Results: In normal cartilage none of the tested growth factors elicited stimulatory effects on the chondrocyte PG synthesis as caused by IGF-1. EGF and TGF beta even caused significant inhibition of chondrocyte PG synthesis. Combination of bFGF or PDGF with IGF-1 exerted significant additional stimulation of the 35S-sulphate incorporation. IL-1 exposed cartilage displayed reactivity to IGF-1 as well as to the other growth factors similar to control cartilage. Cartilage obtained from joints with experimentally-induced arthritis exhibited a state of nonresponsiveness towards all individually tested growth factors as well as growth factor combinations.

Conclusion: Arthritis causes nonresponsiveness to stimulation of chondrocyte PG synthesis by the tested growth factors, which might be caused by a general receptor function defect.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Arthritis, Experimental / metabolism*
  • Cartilage, Articular / drug effects*
  • Cartilage, Articular / metabolism
  • Epidermal Growth Factor / pharmacology
  • Female
  • Fibroblast Growth Factor 2 / pharmacology
  • Growth Substances / pharmacology*
  • In Vitro Techniques
  • Insulin-Like Growth Factor I / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Patella
  • Platelet-Derived Growth Factor / pharmacology
  • Prostaglandins / biosynthesis*
  • Transforming Growth Factor beta / pharmacology

Substances

  • Growth Substances
  • Platelet-Derived Growth Factor
  • Prostaglandins
  • Transforming Growth Factor beta
  • Fibroblast Growth Factor 2
  • Epidermal Growth Factor
  • Insulin-Like Growth Factor I